EGFL6 promotes colorectal cancer cell growth and mobility and the anti‐cancer property of anti-EGFL6 antibody

Abstract Background The availability of a reliable tumor target for advanced colorectal cancer (CRC) therapeutic approaches is critical since current treatments are limited. Epidermal growth factor-like domain 6 (EGFL6) has been reported to be associated with cancer development. Here, we focused on...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Ting-Yi Sung, Han-Li Huang, Chun-Chun Cheng, Fu-Ling Chang, Po-Li Wei, Ya-Wen Cheng, Cheng-Chiao Huang, Yu-Ching Lee, Wei-Chun HuangFu, Shiow-Lin Pan
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMC 2021-03-01
Edice:	Cell & Bioscience
Témata:	EGFL6 Colorectal cancer EGFR/αvβ3 Tumor progression Therapeutic antibody
On-line přístup:	https://doi.org/10.1186/s13578-021-00561-0
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!